galantyl galantamine (as hydrobromide) 8 mg modified release capsule blister pack
alphapharm pty ltd - galantamine hydrobromide, quantity: 10.256 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; hydrogenated vegetable oil; povidone; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; polyvinyl acetate - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.
galantyl galantamine (as hydrobromide) 24 mg modified release capsule blister pack
alphapharm pty ltd - galantamine hydrobromide, quantity: 30.768 mg - capsule, modified release - excipient ingredients: hydrogenated vegetable oil; povidone; magnesium stearate; colloidal anhydrous silica; sodium lauryl sulfate; polyvinyl acetate; titanium dioxide; allura red ac; potable water; gelatin; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.
galantyl galantamine (as hydrobromide) 16 mg modified release capsule blister pack
alphapharm pty ltd - galantamine hydrobromide, quantity: 20.512 mg - capsule, modified release - excipient ingredients: povidone; magnesium stearate; hydrogenated vegetable oil; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; colloidal anhydrous silica; polyvinyl acetate - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.
galantamine sr scp galantamine (as hydrobromide) 24mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; hypromellose; magnesium stearate; titanium dioxide; indigo carmine; erythrosine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sz galantamine (as hydrobromide) 16mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: hypromellose; gelatin; ethylcellulose; microcrystalline cellulose; iron oxide red; titanium dioxide; magnesium stearate - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sr scp galantamine (as hydrobromide) 16mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; gelatin; magnesium stearate; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sz galantamine (as hydrobromide) 8mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; gelatin; ethylcellulose; microcrystalline cellulose; titanium dioxide; hypromellose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sz galantamine (as hydrobromide) 24mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; hypromellose; magnesium stearate; titanium dioxide; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; erythrosine; indigo carmine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine sr scp galantamine (as hydrobromide) 8mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; ethylcellulose; titanium dioxide; hypromellose; gelatin; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine oral solution 4mg/ml
syri limited - galantamine - oral solution - galantamine 4 mg/ml - psychoanaleptics